MedTrace Logo

Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain

NCT06547450 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-03-03

No results posted yet for this study

Summary

The aim of this project is to contribute to the improvement of psychological care received in primary care (PC), through the study of the cost-effectiveness and acceptability of the Unified Protocol for the treatment of emotional disorders in brief groups in primary care services in Spain (PU-AP) for the treatment of emotional disorders (EDs), the most prevalent in our society. To do so, a pilot study will be carried out, and, subsequently, a randomized clinical trial to study the efficacy, cost-effectiveness and acceptability of the Unified Protocol for the transdiagnostic treatment of EDs, applied in 5 or 8 group sessions. Finally, the researchers will analyze whether there are specific patient profiles that will benefit more from one or the other condition. The results will contribute to the personalization of the psychological treatment of users with EDs attending PC in the Spanish public health system.

Conditions

  • Emotional Disorder
  • Anxiety Disorders
  • Depressive Disorder

Interventions

BEHAVIORAL

5-session UP condition

Unified Protocol (UP) for transdiagnostic treatment of EDs in 5-session

BEHAVIORAL

8-session UP condition

Unified Protocol (UP) for transdiagnostic treatment of EDs in 8-session

Sponsors & Collaborators

  • Instituto de Investigación Sanitaria Aragón

    lead OTHER

Principal Investigators

  • Jorge Osma, Ph.D · Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-10
Primary Completion
2026-09-01
Completion
2027-09-01

Countries

  • Spain

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06547450 on ClinicalTrials.gov